MedTrace Logo

Observational Study in COVID-19 Patients Treated With Remdesivir

NCT05239988 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1004

Last updated 2024-02-28

No results posted yet for this study

Summary

Taking into account the high number of COVID-19 patients managed in Italian Internal Medicine, Fadoi Foundation (Italian Scientific Society of Internal Medicine) promotes a national retrospective observational study in patients treated with Remdesivir, analyzing the characteristics of patients and their clinical outcome during hospitalization, and thus providing real-life information potentially useful to integrate the evidence produced by studies conducted under experimental conditions and available in the literature.

Conditions

  • Hospitalization

Interventions

OTHER

no experimental intervention

There will not be any experimental intervention. The study will be conducted according with normal clinical practice

Sponsors & Collaborators

  • Fadoi Foundation, Italy

    lead OTHER

Principal Investigators

  • Andrea Fontanella, MD · FADOI FOUNDATION

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-24
Primary Completion
2022-06-30
Completion
2022-06-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05239988 on ClinicalTrials.gov